1-18 of 18
Hui Shi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Compilation of Experiences in Utilizing CAR-T Cell Therapy for Richter's Transformation

Shaomei Feng, Teng Xu, Haidi Liu, Peihao Zheng, Lixia Ma, Hui SHI, Tong Wu, Fan Yang, Kai HU, Xiaoyan Ke
Journal: Blood
Blood (2023) 142 (Supplement 1): 4638.
https://doi.org/10.1182/blood-2023-182797
Published: 2023
Journal Articles

Assessment of Activities of Daily Living (ADL)Scale Can be Used to Predict Overall Survival after CAR-T Cell Therapy in Elderly Patient(over 70 years of age) with Refractory/Relapsed B-Cell Lymphoma

Fan Yang, Rui Liu, Teng Xu, Zhonghua Fu, Peihao Zheng, Shaomei Feng, Yuelu Guo, Hui SHI, Lixia Ma, Guoai Su, Biping Deng, Xiaoyan Ke, Kai HU
Journal: Blood
Blood (2023) 142 (Supplement 1): 6922.
https://doi.org/10.1182/blood-2023-177836
Published: 2023
Journal Articles

The Mini-Teddi-R Treatment Demonstrated a High Rate of Remission in Patients with DLBCL Involving the CNS Who Had Previously Been Exposed to BTK Inhibitors

Hui SHI, Kai HU, Xiaoyan Ke
Journal: Blood
Blood (2023) 142 (Supplement 1): 4507.
https://doi.org/10.1182/blood-2023-184452
Published: 2023
Journal Articles

Interpreting Immune Reconstitution and Clinical Outcome By Single-Cell Transcriptomic Analysis in T-ALL Patients Undergoing Donor-Derived CD7 CAR-T Immunotherapy

Hui Shi, Kai Hu, Fan Yang, Zhuojun Liu, Jia Liu, Wei Chen, Jian Yu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10422–10423.
https://doi.org/10.1182/blood-2022-165035
Published: 2022
Journal Articles

Exploring the Efficiency and Survival of CAR T-Cell Therapy in DLBCL Patients with MYC and/or TP53 Abnormalities

Peihao Zheng, Rui Liu, Teng Xu, Fan Yang, Shaomei Feng, Yuelu Guo, Lixia Ma, Hui Shi, Hongwei Yu, Biping Deng, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7548–7549.
https://doi.org/10.1182/blood-2022-168018
Published: 2022
Journal Articles

Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed B-Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy

Fan Yang, Rui Liu, Teng Xu, Peihao Zheng, Shaomei Feng, Yuelu Guo, Lixia Ma, Hui SHI, Biping Deng, Xiaoyan Ke, Tong Wu, Kai Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10384–10385.
https://doi.org/10.1182/blood-2022-164446
Published: 2022
Journal Articles

Daratumumab-Primed Venetoclax Combined with Cage for Refractory/Relapsed T-Lymphoblastic Leukemia/Lymphoma Patients: Single-Arm, Open-Label, Phase I Study

Hui Shi, Kai Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 9480–9481.
https://doi.org/10.1182/blood-2022-165210
Published: 2022
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning Including Donor Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma and Multiple Myeloma

Fan Yang, Hui Shi, Yang Lei, Ruiting Li, Teng Xu, Biping Deng, Tong Wu, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2021) 138 (Supplement 1): 557.
https://doi.org/10.1182/blood-2021-146767
Published: 2021
Journal Articles

Secondary Humanized CAR T Cells Salvage Therapy Improves Survival of R/R DLBCL Patients Failed to Murine CD19-CAR T Cells Therapy

Hui SHI, Kai Hu, Xiaoyan Ke, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4836.
https://doi.org/10.1182/blood-2021-150108
Published: 2021
Journal Articles

Auto Hematopoietic Stem Cell Transplantation Combined with Another Target Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Failure of Murinized CD19-CAR-T Therapy

Kai Hu, Fan Yang, Rui Liu, Teng Xu, Peihao Zheng, Shaomei Feng, Yuelu Guo, Hui Shi, Biping Deng, Xiaoyan Ke, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 657.
https://doi.org/10.1182/blood-2021-146801
Published: 2021
Journal Articles

Transcriptomic landscape of circulating mononuclear phagocytes in Langerhans cell histiocytosis at the single-cell level

Hui Shi, Han He, Lei Cui, Egle Kvedaraite, Zhilei Bian, Tao Huang, Christopher Z. W. Lee, Zhigang Li, Jian He, Yandong Gong, Zongcheng Li, Jie Zhou, Yang Zeng, Xianlong Li, Yanli Ni, Zhijie Bai, Chen Liu, Na Li, Honghao Ma, Dong Wang, Yu Lan, Florent Ginhoux, Rui Zhang, Bing Liu
Journal: Blood
Blood (2021) 138 (14): 1237–1248.
https://doi.org/10.1182/blood.2020009064
Published: 2021
Includes: Supplemental data
Journal Articles

ASXL2 Is Required for Normal Hematopoiesis and Loss of a sxl2 Leads to Myeloid Malignancies in Mice

Jianping Li, Fuhong He, PhD, Peng Zhang, PhD, Shi Chen, MD PhD, Hui Shi, Yanling Sun, Guo Ying, Hui Yang, Stephen D. Nimer, MD, Qian-Fei Wang, Mingjiang Xu, MD PhD, Feng-Chun Yang, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1509.
https://doi.org/10.1182/blood.V128.22.1509.1509
Published: 2016
Journal Articles

Upregulation of Mir-99a Is Associated with Poor Prognosis of Acute Myeloid Leukemia and Promotes Myeloid Leukemia Cell Expansion

Xiaohui Si, Xiaoyun Zhang, Xing Hao, Yunan Li, Zizhen Chen, Hui Shi, Feng-Chun Yang, MD PhD, Yuan Zhou, PhD
Journal: Blood
Blood (2016) 128 (22): 5086.
https://doi.org/10.1182/blood.V128.22.5086.5086
Published: 2016
Journal Articles

Impact of Chemotherapy Delay on Overall Survival for AML with I DH1/2 Mutations: A Study in Adult Chinese Patients

Jing Han Wang, PhDMD, Qi Guo, Zhi Xin Ma, Qiu Ling Ma, Meng Xia Yu, Xiu Feng Yin, Sha Sha Lu, Qiong Hong Xie, Yue Hong Jiang, Dan Shen, li Ya Ma, Hui Shi, Wen Juan Yu, Ye Jiang Lou, Ying Li, Min Yang, Gai Xiang Xu, Li Ping Mao, Jian Hu Li, Fan Ping Wang, Dong Mei Wang, Ju Ying Wei, Hong Yan Tong, Jian Huang, Jie Jin, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4905.
https://doi.org/10.1182/blood.V126.23.4905.4905
Published: 2015
Journal Articles

Combined Loss of Tet1 and Tet2 Promotes B-Cell, but Not Myeloid Malignancies in Mice

Zhigang Zhao, MDPhD, Lin Li, PhD, Meelad Dawlaty, PhD, Feng Pan, PhD, Zhe Li, PhD, Yuan Zhou, PhD, Hui Shi, MD PhD, Shi Chen, MD PhD, Ophelia Weeks, PhD, Weiping Yuan, PhD, Hongyu Ni, PhD, Feng-Chun Yang, MD PhD, Rudolph Jaenisch, PhD, Peng Jin, MDPhD, Mingjiang Xu, MDPhD
Journal: Blood
Blood (2015) 126 (23): 3650.
https://doi.org/10.1182/blood.V126.23.3650.3650
Published: 2015
Journal Articles

Cell Autonomous Defects of Mesenchymal Stem Progenitor Cells of Patients with CMML Contribute to Impaired Hematopoietic Supportive Activity

Hui Shi, MD PhD, Rong Li, Wen Xing, MD, Jie Bai, MD PhD, Xiaohui Si, PhD, Mingjiang Xu, MD PhD, Yuan Zhou, PhD, Feng-Chun Yang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3599.
https://doi.org/10.1182/blood.V126.23.3599.3599
Published: 2015
Journal Articles

ASXL1 Is a Key Regulator for Erythroid Development and Asxl1 Loss Impairs Erythropoiesis In Vivo

Shohei Yamamoto, MD PhD, Hui Shi, MD PhD, Shi Chen, MD PhD, Peng Zhang, PhD, Yuan Zhou, PhD, Mingjiang Xu, MD PhD, Feng-Chun Yang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3644.
https://doi.org/10.1182/blood.V126.23.3644.3644
Published: 2015
Journal Articles

Survival and Prognosis of Chinese Patients with Post-Polycythemia Vera Myelofibrosis

Jie Bai, MD PhD, Yuan Zhou, PhD, Lei Zhang, MD, Mengyao Sheng, Rong Li, Hui Shi, Yanping Xue, MD, Mingjiang Xu, MD PhD, Feng-Chun Yang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1607.
https://doi.org/10.1182/blood.V126.23.1607.1607
Published: 2015